University of California San Francisco
Helen Diller Family Comprehensive Cancer Center
Johannes Kratz, MD

Johannes Kratz, MD

Assistant Professor in Residence, Cardiothoracic Surgery, UCSF

Cancer Center Program Memberships

Experimental Therapeutics

Education

  • Stanford University, Palo Alto, CA, B.A. (with Distinction), 06/1999, Philosophy
  • Stanford University, Palo Alto, CA, B.S. (with Honors with Distinction), 06/1999, Biological Sciences
  • Stanford University, Palo Alto, CA, M.A., 06/2000, Philosophy
  • Harvard Medical School, Boston, MA, M.D. (Magna cum laude), 06/2006
  • Massachusetts General Hospital, Boston, MA, Residency, 06/2014, General Surgery
  • University of California, San Francisco, CA, Post-Doctoral Research Fellowship, 06/2011, Thoracic Oncology
  • University of California, San Francisco, CA, Fellowship, 06/2017, Cardiothoracic Surgery

Professional Experience

  1. 2017-present
    Assistant Professor in Residence, Cardiothoracic Surgery, University of California, San Francisco
  2. 2017-present
    Associate Program Director, Cardiothoracic Surgery, University of California, San Francisco
  3. 2017-present
    Director, Minimally Invasive and Robotic Thoracic Surgery, Cardiothoracic Surgery, University of California, San Francisco
  4. 2017-present
    Program Leader, Enhanced Recovery After Thoracic Surgery, Cardiothoracic Surgery, University of California, San Francisco

Honors & Awards

  • 2005
    Soma Weiss Scholar Award, Harvard Medical School
  • 2006
    John E. Thayer Scholarship Award, Harvard Medical School
  • 2010
    Willard M. Daggett Award, Massachusetts General Hospital
  • 2011
    President's Conference Selection, World Conference on Lung Cancer, International Association for the Study of Lung Cancer
  • 2012
    First Place, Oral Presentation, Harvard Medical School Surgery Research Conference, Harvard Medical School
  • 2012
    Partners HealthCare Resident/Fellow as Teacher Award (awarded to one resident among all specialties across all eleven Partners HealthCare hospitals), Partners HealthCare
  • 2017
    UCSF Health Exceptional Physician Award (awarded for Professionalism, Respect, Integrity, Diversity and Excellence), UCSF
  • 2018
    Van Auken Endowed Chair in Thoracic Oncology, University of California, San Francisco

Selected Publications

  1. Kratz JR, Haro GJ, Cook NR, He J, Van Den Eeden SK, Woodard GA, Gubens MA, Jahan TM, Jones KD, Kim IJ, He B, Jablons DM, Mann MJ. Incorporation of a Molecular Prognostic Classifier Improves Conventional Non-Small Cell Lung Cancer Staging. J Thorac Oncol. 2019 Jul; 14(7):1223-1232.
    View on PubMed
  2. Lancaster EM, Jablons D, Kratz JR. Applications of Next-Generation Sequencing in Neoantigen Prediction and Cancer Vaccine Development. Genet Test Mol Biomarkers. 2019 Mar 22.
    View on PubMed
  3. Haro GJ, Seeley EJ, Jablons DM, Kratz JR. Central Airway Obstruction Due to Tracheal Glomus Tumor. Thorac Cardiovasc Surg Rep. 2018 Jan; 7(1):e43-e45.
    View on PubMed
  4. Ramirez JL, Kratz JR, Wieselthaler GM. Giant right coronary artery aneurysm presenting as cardiac tamponade. Interact Cardiovasc Thorac Surg. 2018 Nov 01; 27(5):787-789.
    View on PubMed
  5. Ramirez J, Wieselthaler G, Kratz J. Intraoperative identification and treatment of a giant right coronary artery aneurysm. Multimed Man Cardiothorac Surg. 2018 Jul 24; 2018.
    View on PubMed
  6. Ramirez JL, Urisman A, Kukreja J, Kratz JR. Surgical Management of Pulmonary Mucormycosis in Third-Trimester Pregnancy. Thorac Cardiovasc Surg Rep. 2018 Jan; 7(1):e27-e29.
    View on PubMed
  7. Woodard GA, Wang SX, Kratz JR, Zoon-Besselink CT, Chiang CY, Gubens MA, Jahan TM, Blakely CM, Jones KD, Mann MJ, Jablons DM. Adjuvant Chemotherapy Guided by Molecular Profiling and Improved Outcomes in Early Stage, Non-Small-Cell Lung Cancer. Clin Lung Cancer. 2018 01; 19(1):58-64.
    View on PubMed
  8. Kratz JR, Woodard G, Jablons DM. Management of Lung Cancer Invading the Superior Sulcus. Thorac Surg Clin. 2017 May; 27(2):149-157.
    View on PubMed
  9. Shah JA, Patel MS, Kratz JR, Markmann JF, Vagefi PA. High risk, high reward: An analysis of outcomes for candidates awaiting hepatic re-transplantation. Ann Hepatol. 2016 Nov - Dec; 15(6):888-894.
    View on PubMed
  10. Shah JA, Patel MS, Kratz JR, Markmann JF, Vagefi PA.  High risk, high reward: An analysis of outcomes for candidates awaiting hepatic re-transplantation. Ann Hepatol. 2016 Nov-Dec 2016; 15(6):888-894.
    View on PubMed
  11. Hirata T, Zheng Q, Chen Z, Kinoshita H, Okamoto J, Kratz J, Li H, Lui N, Do H, Cheng T, Tseng HH, Koizumi K, Shimizu K, Zhou HM, Jablons D, He B. Wnt7A is a putative prognostic and chemosensitivity marker in human malignant pleural mesothelioma. Oncol Rep. 2015 Apr; 33(4):2052-60.
    View on PubMed
  12. Patel MS, Kohn R, Kratz JR, Shah JA, Markmann JF, Vagefi PA. The race to liver transplantation: a comparison of patients with and without hepatocellular carcinoma from listing to post-transplantation. J Am Coll Surg. 2015 Jun; 220(6):1001-7.
    View on PubMed
  13. Kohn R, Kratz JR, Markmann JF, Vagefi PA. The migrated liver transplantation candidate: insight into geographic disparities in liver distribution. J Am Coll Surg. 2014 Jun; 218(6):1113-8.
    View on PubMed
  14. Kratz JR, Tham PT, Mulvihill MS, Ziaei F, Ray MR, Hurst JW, Segal MR, Berryman DM, Chu W, He B, Jablons DM, Mann MJ. Analytical validation of a practical molecular assay prognostic of survival in nonsquamous non-small cell lung cancer. Diagn Mol Pathol. 2013 Jun; 22(2):65-9.
    View on PubMed
  15. Kratz JR, Mann MJ, Jablons DM. International trial of adjuvant therapy in high risk stage I non-squamous cell carcinoma identified by a 14-gene prognostic signature. Transl Lung Cancer Res. 2013 Jun; 2(3):222-5.
    View on PubMed
  16. Mann MJ, Jablons DM, Kratz JR. Prognostic assay in small, node-negative non-small cell lung cancer--reply. JAMA. 2013 Feb 27; 309(8):769-70.
    View on PubMed
  17. Mulvihill MS, Kratz JR, Pham P, Jablons DM, He B. The role of stem cells in airway repair: implications for the origins of lung cancer. Chin J Cancer. 2013 Feb; 32(2):71-4.
    View on PubMed
  18. Kratz JR, Van den Eeden SK, He J, Jablons DM, Mann MJ. A prognostic assay to identify patients at high risk of mortality despite small, node-negative lung tumors. JAMA. 2012 Oct 24; 308(16):1629-31.
    View on PubMed
  19. Choi H, Kratz J, Pham P, Lee S, Ray R, Kwon YW, Mao JH, Kang HC, Jablons D, Kim IJ. Development of a rapid and practical mutation screening assay for human lung adenocarcinoma. Int J Oncol. 2012 Jun; 40(6):1900-6.
    View on PubMed
  20. Kratz JR, He J, Van Den Eeden SK, Zhu ZH, Gao W, Pham PT, Mulvihill MS, Ziaei F, Zhang H, Su B, Zhi X, Quesenberry CP, Habel LA, Deng Q, Wang Z, Zhou J, Li H, Huang MC, Yeh CC, Segal MR, Ray MR, Jones KD, Raz DJ, Xu Z, Jahan TM, Berryman D, He B, Mann MJ, Jablons DM. A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies. Lancet. 2012 Mar 03; 379(9818):823-32.
    View on PubMed

Go to UCSF Profiles, powered by CTSI